Irina  Ridley net worth and biography

Irina Ridley Biography and Net Worth

General Counsel of NeuroPace
Irina Ridley has served as our General Counsel and Corporate Secretary since November 2020. Ms. Ridley previously served as Chief Counsel at Myriad Genetics, Inc., a precision medicine company, from August 2018 to November 2020, where she was responsible for corporate legal matters. From August 2016 to August 2018, she served as Associate General Counsel and Privacy Officer at Counsyl Inc., a genetic testing company, where prior to its acquisition by Myriad Genetics, Inc., she was responsible for corporate legal matters. From2014 to August 2016, she served as Compliance and Privacy Officer at Omada Health, a digital health company, where she was the first attorney and was responsible for building out Omada Health’s compliance and privacy programs. Prior to that, from 2011 to 2014, Ms. Ridley worked in management consulting, serving in roles of increasing responsibility at Deloitte Tax, LLP, and PricewaterhouseCoopers. Ms. Ridley has served on the Alumni Board of Directors of Albany Law School since July 2016 and previously served on the Board of Directors of Women in Security and Privacy from May 2016 to October 2017. Ms. Ridley earned a B.S. and an M.B.A. from the Rensselaer Polytechnic Institute and a J.D. from Albany Law School of Union University.

What is Irina Ridley's net worth?

The estimated net worth of Irina Ridley is at least $593,048.30 as of June 8th, 2022. Ms. Ridley owns 61,139 shares of NeuroPace stock worth more than $593,048 as of November 23rd. This net worth evaluation does not reflect any other assets that Ms. Ridley may own. Learn More about Irina Ridley's net worth.

How do I contact Irina Ridley?

The corporate mailing address for Ms. Ridley and other NeuroPace executives is , , . NeuroPace can also be reached via phone at 650-237-2700 and via email at [email protected]. Learn More on Irina Ridley's contact information.

Has Irina Ridley been buying or selling shares of NeuroPace?

Irina Ridley has not been actively trading shares of NeuroPace during the last ninety days. Most recently, Irina Ridley sold 2,500 shares of the business's stock in a transaction on Wednesday, June 8th. The shares were sold at an average price of $5.78, for a transaction totalling $14,450.00. Following the completion of the sale, the general counsel now directly owns 61,139 shares of the company's stock, valued at $353,383.42. Learn More on Irina Ridley's trading history.

Who are NeuroPace's active insiders?

NeuroPace's insider roster includes Frank Fischer (Director), and Irina Ridley (General Counsel). Learn More on NeuroPace's active insiders.

Are insiders buying or selling shares of NeuroPace?

In the last twelve months, insiders at the sold shares 24 times. They sold a total of 813,294 shares worth more than $9,303,620.65. The most recent insider tranaction occured on October, 25th when Major Shareholder Ltd. Kck sold 223,991 shares worth more than $1,220,750.95. Insiders at NeuroPace own 22.2% of the company. Learn More about insider trades at NeuroPace.

Information on this page was last updated on 10/25/2024.

Irina Ridley Insider Trading History at NeuroPace

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/8/2022Sell2,500$5.78$14,450.0061,139View SEC Filing Icon  
2/28/2022Sell1,470$7.54$11,083.80View SEC Filing Icon  
4/21/2021Buy2,352$17.00$39,984.002,352View SEC Filing Icon  
See Full Table

Irina Ridley Buying and Selling Activity at NeuroPace

This chart shows Irina Ridley's buying and selling at NeuroPace by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NeuroPace Company Overview

NeuroPace logo
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Read More

Today's Range

Now: $9.70
Low: $8.91
High: $9.70

50 Day Range

MA: $7.13
Low: $5.90
High: $9.70

2 Week Range

Now: $9.70
Low: $5.45
High: $18.15

Volume

67,025 shs

Average Volume

97,227 shs

Market Capitalization

$289.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.79